Literature DB >> 11694750

Reported exposure to chickenpox: a predictor of positive anti-varicella-zoster antibodies in parturient women.

N Linder1, A Ferber, U Kopilov, Z Smetana, A Barzilai, E Mendelson, L Sirota.   

Abstract

OBJECTIVE: To determine the positive and negative predictive values of recalled exposure to chickenpox for identifying anti-varicella-zoster virus (VZV) seropositive parturient women.
METHODS: Blood samples were taken from laboring women during February 1998: All women completed questionnaires concerning a history of chickenpox in themselves and their children. Anti-VZV antibodies were determined by the immunofluorescent antibodies to membrane antigen (IFAMA) technique.
RESULTS: Three hundred and twenty-seven women formed the study population; 239 women (73.1%) recalled chickenpox in themselves or their children, of which 229 (95.8%) were seropositive for anti-VZV antibodies. Of the 88 women who gave a negative/uncertain history of chickenpox 82 (93.2%) were seropositive and 6 (6.8%) were seronegative. All 87 mothers who were certain their children had had chickenpox were seropositive, including all 16 mothers who had a negative personal history. Thus, a woman with a history of chickenpox had a positive predictive value of 95.8%, and a woman with a lack of history had a negative predictive value of 6.8% (sensitivity 73.6%, specificity 37.5%), while a positive history of chickenpox in a child had a positive predictive value of 100%.
CONCLUSIONS: Most women with no known history of VZV infection have evidence of prior exposure by serologic testing. Moreover, 100% of women with a negative history who were exposed to VZV in their children were protected from the disease. Therefore, mothers exposed to VZV during pregnancy can be reassured that most likely they are protected. However, the practice of testing all pregnant women exposed to the disease should be continued. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694750     DOI: 10.1159/000053952

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  4 in total

1.  Seroprevalence of varicella antibodies among pregnant women in Lyon-France.

Authors:  M Saadatian-Elahi; Y Mekki; C Del Signore; B Lina; T Derrough; E Caulin; J Thierry; P Vanhems
Journal:  Eur J Epidemiol       Date:  2007-05-30       Impact factor: 12.434

2.  Seroprevalence of varicella-zoster virus among pregnant women in two teaching hospitals, Tehran, Iran.

Authors:  Mahshid Talebi-Taher; Maryam Kashanian; Katayoon Khalili
Journal:  Iran J Microbiol       Date:  2014-02

Review 3.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

4.  Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Authors:  Nigel Field; Gayatri Amirthalingam; Pauline Waight; Nick Andrews; Shamez N Ladhani; Albert Jan van Hoek; Peter A C Maple; Kevin E Brown; Elizabeth Miller
Journal:  Vaccine       Date:  2013-07-16       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.